Kennedy Capital Management, Inc. Athenex, Inc. Transaction History

Kennedy Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$15.53 - $19.97 $2.35 Million - $3.02 Million	-151,140 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$15.88 - $19.5 $2.74 Million - $3.37 Million	-172,716 Reduced 53.33%	151,140 $2.82 Million
Q1 2018 May 14, 2018	BUY	$13.53 - $17.47 $4.38 Million - $5.66 Million	323,856 New	323,856 $5.51 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.